SBWire

Although attitudes towards tanning vary, consumers in all regions are increasingly looking to avoid sun damage, with rising levels of awareness driving sun protection sales across the globe. Developed markets are reaching saturation, but innovative product developments are keeping sales buoyant. With the lines blurring between skin care and sun care, sun care needs to keep health benefits at the forefront of development and marketing, while delivering the beauty benefits of skin care.

Continued price competition between the largest carbonate brands caused a decline in year-on-year unit prices in current terms. The trend that started in 2004 with the introduction of Kola Real, an economy cola brand from Industrias San Miguel del Caribe SA, only accelerated in 2011. As carbonate manufacturers continue to compete for space on the shelves of the independent small grocers (which provided 75% of the sales of carbonates in volume terms), price wars have resulted in an almost...

Retail value sales of analgesics in the UK declined marginally in 2011, to GBP518 million. The overall category continues to suffer in value terms from the growth of private label. Consumers are becoming increasingly canny about the type of products which are available and are increasingly willing to purchase on ingredient rather than brand name.

The economic downturn and maturity were the key reasons behind bottled water registering total volume growth of just 1% in 2011. With per capita consumption being among the highest in Europe, it was very difficult for manufacturers to increase sales. As a result, companies focused on growing sales of carbonated water and increasing their promotions and advertising to maintain share

"AltaGas Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into "AltaGas Ltd.". The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company's business structure, operations and products, and provides an analysis of its key revenue lines.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Poland. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines, LNG terminals and underground gas storage facilities) in Poland. The report compares the investment environment in Poland with other countries in the region. The profiles of the major companies operating in the natural gas sector in Poland together with the latest news and deals are also included in the report.

GlobalData's clinical trial report, "Venous Leg Ulcers Global Clinical Trials Review, H1, 2012" provides data on the Venous Leg Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Leg Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Elixir Medical Corporation (Elixir Medical) is a medical device company, based in the US. The company develops drug eluting stent systems for localized drug delivery for the treatment of cardiovascular diseases. Its product pipeline includes coronary stent systems, stents for small vessels, drug eluting stent systems, fully absorbable drug eluting scaffold systems and drug eluting balloons. Elixir Medical develops drug eluting stent platforms using biodegradable polymers, durable polymers and release technologies. The company markets its product through brand DESyne, DESolve and Core. Its next-generation drug-eluting stent systems are designed to optimize local drug delivery to provide a safe and effective treatment for cardiovascular diseases. Elixir Medical is headquartered in Sunnyvale, California, the US.

Bolton Medical, Inc. (Bolton Medical) is a medical device company, based in the US. The company designs, develops, manufactures and distributes endovascular devices. Its products include endovascular devices, interventional coronary, peripheral and accessories. The company provides Thoracic Endovascular Stent Grafts called Relay NBS Thoracic Stent Grafts and Relay Plus, which is designed for the thoracic aorta, when treating aneurysms and dissections. Its products offered by the company are certified with CE mark. The company operates as a subsidiary of Werfen Hospital Group. It has a wide distribution network in more than 12 countries worldwide. Bolton Medical is headquartered in Florida, the US.

Skyline Diagnostics BV (Skyline Diagnostics) is a pharmaceutical and healthcare company, based in the Netherlands. It develops and commercializes microarray-based diagnostic tests using molecular signatures for personalized medicine in the field of oncology. The company's product pipeline includes acute lymphatic leukemia profiler, multiple myeloma profiler and brain profiler. Its AML profiler simplifies the challenging task to recognize acute myeloid leukemia subtypes and make individualized therapy decisions. Skyline Diagnostics partners include Affymetrix, Crosslinks, Iperion, Rescop and Myraqa. Its technologies include personalized medicine in cancer and microarray technology. The company was incorporated in the year 2005. Skyline Diagnostics is headquartered in Rotterdam, the Netherlands.

This report gives detailed information on the Yemen power market. It examines the country's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market's regulatory structure, import and export trends, competitive landscape and leading active and upcoming power projects is provided. The report also analyses the power sector of the country on 6 broad parameters which include supply security, regulatory scenario, infrastructure, macroeconomics, competition and future potential of the power sector. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the country ranking in the Middle East region.

GlobalData's clinical trial report, "Portal Hypertension Global Clinical Trials Review, H1, 2012" provides data on the Portal Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Portal Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Portal Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the Denmark Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Proving up Black Sea and Mediterranean deposits is a priority for Turkey, as this will enable it to reduce its dependence on imported fuel, particularly from Russia where pricing disputes are the order of the day. Turkey remains part of the gas transit equation, which gives it extra negotiating power when it comes to purchase agreements.

The Serbian Retail Report examines the long-term potential of the local consumer market, but flags shortterm concerns about the impact on Serbia's economic outlook of fiscal austerity measures.

The Solar Energy Market in China is part of Netscribes' Power Industry Series reports. The market will be boosted by the increasing demand for energy coupled with planned transformation from conventional to renewable energy sources.

The Electric Vehicle Market in China is part of Netscribes' Automobile Industry Series reports. Led by supportive government policies the electric vehicle market in China is expected to witness robust growth.

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years.

"Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Global Hotel Supplier Industry 2012-2013: Survey Intelligence" is a new report by Timetric that analyzes how supplier media spend and marketing sales strategies are set to change in the hotel industry during 2012-2013. This report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading suppliers. The report also identifies future growth of buyers and suppliers, M&A and investment expectations. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

The UK's life insurance segment is highly concentrated with the 10-leading companies accounting a collective market share of 83.7% of the total written premiums in 2010. The leading insurer was Aviva Plc, which accounted for a market share of 13.0%. Aviva Plc is the sixth-largest insurance group in the world and has over 53 million customers. In 2010, the firm recorded a CAGR of 8.0% in terms of gross written premium income. Standard Life Plc posted a market share of 12.8% of the total business written in 2010. Despite a CAGR of 8.9% in 2010 compared to figures from 2009, the company has been able to maintain its position by providing unique products such as SIPP, corporate pensions and Wrap.

This report provides the latest asset allocations of French HNWIs. The report also includes projections of the volume, wealth and asset allocation of French HNWIs to 2015 and a comprehensive and robust background of the local economy, including, uniquely, detailed analysis of economic and political risks to HNWI wealth creation.

The Chinese consumer finance market recorded a compound annual growth rate (CAGR) of 28.33% during the review period (2007-2011). It is projected to retain a high CAGR of 24.3% over the forecast period (2012-2016). The strong growth will be driven by the country's improving macroeconomic fundamentals and rising domestic demand for consumer finance products. Housing loans is the largest category in the Chinese consumer finance market. It recorded a CAGR of 24.65% during the review period. The housing loans category is projected to record a CAGR of 20.86% over the forecast period. The Chinese population has traditionally been skeptical of using credit to finance anything other than housing. However, as the country's disposable income levels increase, consumers are becoming more willing to access personal loans. The changing lifestyles in China have encouraged the growth of credit cards. The number of credit cards issued in China increased at a CAGR of 27.47% during 2008-2011. Banks are offering lucrative schemes to encourage people to convert their transactions into equal monthly installments (EMIs), and this is also driving the growth of credit card loans in China. The Chinese government introduced various measures to control the sharp increase in property prices during the review period. These measures prohibited mortgages for third-home purchasers and increased the downpayment for second-home purchases from 50% to 60%. These measures will have an adverse impact on the Chinese housing loan category over the forecast period.

0Energy Drinks in UK by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers sugar-free and regular energy drinks and shots. Energy drinks are marketed with additives specifically designed to increase alertness. Market size comprises sales through all retail channels including direct to consumer including vending machines. Market value is calculated at prices in retailers. Market size for Energy Drinks in UK is given in %, GBP, USD and litres with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for UK. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading medical devices industry executives. It analyzes how demand and growth expectations are set to change in the medical devices industry in 2012-13. The report also provides access to information categorized by company type, company turnover, buyer, supplier and region.

Beer in Italy by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers all alcoholic and non-alcoholic beers. Market size is based on retail (off trade) and non-retail (on trade and food industry) sales. Market size for Beer in Italy is given in litres with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for Italy. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.